Abd Elrhman Enayet1,2, Mohamed Nabil1,3, Mohamed Reda Rady1,2, Yasser Yousef4, Eman Badawy5, Mohamed A El Beltagy6,7. 1. Neurosurgery Department, Children's Cancer Hospital Egypt (CCHE, 57357), Cairo, Egypt. 2. Neurosurgery Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt. 3. Neurosurgery Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt. 4. Pediatric Oncology Department, Children's Cancer Hospital Egypt (CCHE, 57357), Cairo, Egypt. 5. Clinical Research Department, Children's Cancer Hospital, (CCHE, 57357), Cairo, Egypt. 6. Neurosurgery Department, Children's Cancer Hospital Egypt (CCHE, 57357), Cairo, Egypt. Beltagy_mohamed@hotmail.com. 7. Neurosurgery Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt. Beltagy_mohamed@hotmail.com.
Abstract
PURPOSE: To analyze the impact of increasing the extent of resection (EOR) on the survival rates and on the surgical outcome of children with medulloblastoma. METHODS: A series of consecutive 405 children operated for medulloblastoma between July 2007 and April 2018 was identified. The details of pre-operative data, surgical interventions, post-operative complications, and survival rates were analyzed. RESULTS: The Kaplan-Meier (KM) analysis showed no advantage of gross total resection (GTR) over near and subtotal resection regarding over all (OS) (p=0.557) and progression free survival (PFS) (p=0.146). In the same time, increasing the EOR was not associated with higher morbidity. Tumor dissemination at onset correlated to worse OS (KM: p=0.003, OR 1.999, 95% CI: 1.242-3.127; p = 0.004) and PFS (KM: p<0.001, Cox: OR 2.171, 95% CI: 1.406-3.353; p<0.001). OS was significantly affected in patients < 3 years old (KM: p=0.011, OR 2.036, 95% CI: 1.229-3.374; p = 0.006), while PFS was worse among patients who had pre-op seizures (KM: p=0.036, Cox: OR 2.852, 95% CI: 1.046-7.773; p=0.041) or post-op pseudomeningocele (KM: p=0.021, Cox: OR 2.311, 95% CI: 1.123-4.754; p=0.023). CONCLUSIONS: Although surgical excision of medulloblastoma is the standard of care, there was no significant benefit for GTR over near or subtotal resection on the OS or PFS rates that are mainly influenced by the patient's age and tumor dissemination. However, GTR should be targeted, as it is not associated with increased incidence of mutism or other surgery-related complications.
PURPOSE: To analyze the impact of increasing the extent of resection (EOR) on the survival rates and on the surgical outcome of children with medulloblastoma. METHODS: A series of consecutive 405 children operated for medulloblastoma between July 2007 and April 2018 was identified. The details of pre-operative data, surgical interventions, post-operative complications, and survival rates were analyzed. RESULTS: The Kaplan-Meier (KM) analysis showed no advantage of gross total resection (GTR) over near and subtotal resection regarding over all (OS) (p=0.557) and progression free survival (PFS) (p=0.146). In the same time, increasing the EOR was not associated with higher morbidity. Tumor dissemination at onset correlated to worse OS (KM: p=0.003, OR 1.999, 95% CI: 1.242-3.127; p = 0.004) and PFS (KM: p<0.001, Cox: OR 2.171, 95% CI: 1.406-3.353; p<0.001). OS was significantly affected in patients < 3 years old (KM: p=0.011, OR 2.036, 95% CI: 1.229-3.374; p = 0.006), while PFS was worse among patients who had pre-op seizures (KM: p=0.036, Cox: OR 2.852, 95% CI: 1.046-7.773; p=0.041) or post-op pseudomeningocele (KM: p=0.021, Cox: OR 2.311, 95% CI: 1.123-4.754; p=0.023). CONCLUSIONS: Although surgical excision of medulloblastoma is the standard of care, there was no significant benefit for GTR over near or subtotal resection on the OS or PFS rates that are mainly influenced by the patient's age and tumor dissemination. However, GTR should be targeted, as it is not associated with increased incidence of mutism or other surgery-related complications.
Entities:
Keywords:
Hydrocephalous with posterior fossa tumors; Medulloblastoma; Mutism; Pseudomeningocele
Authors: Mohamed Ahmed El Beltagy; Hazem Mostafa Kamal; Hala Taha; Madeha Awad; Nada El Khateeb Journal: Childs Nerv Syst Date: 2010-05-26 Impact factor: 1.475
Authors: Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette Journal: Neuro Oncol Date: 2014-10-13 Impact factor: 12.300
Authors: A Gajjar; R A Sanford; R Bhargava; R Heideman; A Walter; Y Li; J W Langston; J J Jenkins; M Muhlbauer; J Boyett; L E Kun Journal: Pediatr Neurosurg Date: 1996-10 Impact factor: 1.162
Authors: Kaitlin M Christopherson; Julie A Bradley; Ronny L Rotondo; David W Pincus; John A Fort; Christopher G Morris; Nancy P Mendenhall; Robert B Marcus; Daniel J Indelicato Journal: Acta Oncol Date: 2014-07-03 Impact factor: 4.089
Authors: Paul Foreman; Samuel McClugage; Robert Naftel; Christoph J Griessenauer; Benjamin J Ditty; Bonita S Agee; Jay Riva-Cambrin; John Wellons Journal: J Neurosurg Pediatr Date: 2013-06-28 Impact factor: 2.375